Forums before death by AOL, social media and spammers... "We can't have nice things"
|    sci.med.psychobiology    |    Dialog and news in psychiatry and psycho    |    4,736 messages    |
[   << oldest   |   < older   |   list   |   newer >   |   newest >>   ]
|    Message 3,175 of 4,736    |
|    drarwingnuttephd@gmail.com to All    |
|    This Alzheimer's Breakthrough Could Be a    |
|    09 Nov 14 19:33:36    |
      From: unk...@googlegroups.com              This Alzheimer's Breakthrough Could Be a Game Changer       Alice Park @aliceparkny Oct. 13, 2014                       Scientists recreated what goes on in the brains of Alzheimer's patients in a       3D culture dish that could speed development of new drugs for the disease              Researchers have overcome a major barrier in the study of Alzheimer's that       could pave the way for breakthroughs in our understanding of the disease, a       new report shows--and that new understanding could, in turn, pave the way for       drugs that treat or        interrupt the progression of the neurodegenerative condition.                            For decades, animals have been the stand-ins for studying human disease, and       for good reason. Their shorter lifespans mean they can model human conditions       in weeks or months, and their cells can be useful for testing promising new       drug treatments.                            But they haven't been so helpful in studying Alzheimer's disease. Two factors       contribute to the neurodegenerative condition -- the buildup of sticky plaques       of the protein amyloid, and the toxic web of another protein, tau, which       strangles healthy nerve        cells and leaves behind a tangled mess of dead and dying neurons. Despite       attempts by scientists to engineer mice who exhibit both factors, they haven't       been able to generate the tau tangles that contribute to the disease.              Now, Dr. Rudolph Tanzi and Dr. Doo Kim at the Mass General Institute for       Neurodegenerative Diseases at Massachusetts General Hospital, have devised a       work-around that doesn't involve animals. They have developed a way to watch       the disease progress in a        lab dish.              "In this new system that we call 'Alzheimer's-in-a-dish,' we've been able to       show for the first time that amyloid deposition is sufficient to lead to       tangles and subsequent cell death," said Tanzi in a statement.              MORE: Blood Test for Alzheimer's              While autopsies showed evidence of both amyloid and tau in the brain,       Alzheimer's experts have been debating for years which came first -- do       amyloid plaques trigger the formation of tau tangles, or does the presence of       tau cause amyloid to get stickier        and bunch together in the brain? Tanzi and his colleagues showed definitively       for the first time that amyloid is the first step in the Alzheimer's process,       followed by tau tangles. When he blocked the formation of amyloid in the       culture with a known        amyloid inhibitor, tau tangles never formed.              The disease-in-a-dish model is an emerging way of understanding conditions       that either can't be recapitulated accurately in animals, or diseases that       make it difficult to study and test in human patients. In recent years, for       example, scientists have        successfully recreated the process behind amyotrophic lateral sclerosis (ALS),       or Lou Gehrig's disease, using stem cells from patients and allowing them to       develop into the motor neurons that are affected by the disease. The technique       led to a        breakthrough in understanding that a certain population of nerve cells known       as glial cells poison the motor neurons and impede their normal function. Now       experts are focusing on finding ways to control the glial cell activity as       possible treatment for        ALS.              MORE: How Moodiness and Jealousy May Lead to Alzheimer's              Tanzi and his team are hoping that something similar will come from their       model of Alzheimer's.              While the genes responsible for the inherited form of Alzheimer's differ       slightly from those involved in the more common form that affects people as       they age, the end result -- the build up of amyloid plaques and tau tangles --       are the same. So now that        they can see both the clumps of amyloid and the tau tangles, form, they can       start to tease apart the processes that link the two processes together.              That will open the way toward finding drugs or other ways of interrupting the       process more quickly than they could working with animals. It took six to       eight weeks for the cells in the dish to form plaques and then tangles,       compared to a year or so in        mice. "We can now screen hundreds of thousands of drugs in this system that       recapitulates both plaques and tangles...in a matter of months," Tanzi said.       "This was not possible in mouse models." The system also makes it possible to       test these drug        compounds at one-tenth the cost of evaluating them in mice, he said. And that       means that finding a way to prevent Alzheimer's may come both faster and       cheaper than scientists had expected.                     http://time.com/3502215/this-alzheimers-breakthrough-could-be-a-game-changer/              --- SoupGate-Win32 v1.05        * Origin: you cannot sedate... all the things you hate (1:229/2)    |
[   << oldest   |   < older   |   list   |   newer >   |   newest >>   ]
(c) 1994, bbs@darkrealms.ca